The Laboratory tubes

Product

Top Suppliers 86347-15-1 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our company promises all users of the first-class products and the most satisfying post-sale service. We warmly welcome our regular and new customers to join us for Ascorbyl Tetraisopalmitate 129499-78-1, Tofacitinib citrate, AHK-Cu 49557-75-7, The team of our company along with the use of cutting-edge technologies delivers impeccable top quality products supremely adored and appreciated by our shoppers worldwide.
Top Suppliers 86347-15-1 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore Detail:

Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 5kg/month
Order(MOQ): 10g
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial
Package size: 10g/drum
Safety information:  UN 2811 6.1/ PG 1

Mitomycin C

Description

Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.

It is given intravenously to treat upper gastro-intestinal cancers (e.g. esophageal carcinoma), anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours.

Mitomycin C is used in cancers, particularly bladder cancers and intraperitoneal tumours.

Mitomycin C is used in eye surgery where mitomycin C 0.02% is applied topically to prevent scarring during glaucoma filtering surgery and to prevent haze after PRK or LASIK; mitomycin C has also been shown to reduce fibrosis in strabismus surgery.

Mitomycin C is used in esophageal and tracheal stenosis where application of mitomycin C onto the mucosa immediately following dilatation will decrease re-stenosis by decreasing the production of fibroblasts and scar tissue.

Specification (USP/EP)

Item

Specification

Appearance

Blue-violet, crystalline powder

Identification

IR: The IR spectrum of the sample corresponds to the spectrum of reference standard
  HPLC: The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the Assay
pH

6.0~7.5

Water

Not more than 2.5%

Crystallinity

Should conforms

Related Substances
Albomitomycin C

(EP Impurity D)

Not more than 0.5%

Mitomycin B

(EP Impurity C)

Not more than 0.5%

Cinnamamide

(EP Impurity A)

Not more than 0.5%

Mitomycin A

(EP Impurity B)

Not more than 0.5%

Any Individual Unspecified Impurity

Not more than 0.5%

Total Impurities

Not more than 2.0%

Residual Solvents
Methanol

Not more than 3000 ppm

Methylene Chloride

Not more than 600 ppm

Ethyl Acetate

Not more than 5000 ppm

Bacterial Endotoxins

Not more than 10 EU/mg

Assay

Not less than 970 mg/g of Mitomycin


Product detail pictures:

Top Suppliers 86347-15-1 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore detail pictures


Related Product Guide:

Bear "Customer first, Quality first" in mind, we work closely with our customers and provide them with efficient and professional services for Top Suppliers 86347-15-1 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore , The product will supply to all over the world, such as: Bahamas, Cambodia, Munich, Since always, we adhering to the "open and fair, share to get, the pursuit of excellence, and creation of value"values, adhere to the"integrity and efficient, trade-oriented, best way , best valve" business philosophy. Together with our all over the world have branches and partners to develop new business areas, maximum common values. We sincerely welcome and together we share in global resources, opening up new career together with the chapter.
  • We are really happy to find such a manufacturer that ensuring product quality at the same time the price is very cheap.
    5 Stars By Antonia from Serbia - 2018.09.21 11:01
    Speaking of this cooperation with the Chinese manufacturer, I just want to say"well dodne", we are very satisfied.
    5 Stars By Alva from Istanbul - 2018.12.30 10:21